Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Subjects:

Representative immunohistochemical stainings. by Felix L. Herr (21544362)

Subjects:

ROI selection. by Felix L. Herr (21544362)

Subjects:

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Subjects:

Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Group control-after intervention. by Nan Tang (642590)

Subjects:

Flowchart of literature screening process. by Shangtian Wang (20933822)

Subjects:

Seasonal Influenza activity from 2020-2023 in Southeast Asia and Southern Asia. by Nadia Nisar (311028)

Subjects:

The details of literature inclusion and exclusion. by Shangtian Wang (20933822)

Subjects:

Samples Tested and Positive Samples During Pre- and Post-Pandemic Periods. by Nadia Nisar (311028)

Subjects:

Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

Subjects:

Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses. by Beatrice T. Nganso (4114768)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses by regions within Kenya by Beatrice T. Nganso (4114768)

Subjects:

Seasonal Influenza activity from 2017-2023 in SEAR and WPR region. by Nadia Nisar (311028)

Subjects:

Comparison of ten Asian countries with pre and post pandemic influenza activity sources through Flunet. by Nadia Nisar (311028)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Basic characteristics of included literature. by Shangtian Wang (20933822)

Subjects: